Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Garcia

Showing results (341-350 of 455) with videos related to

Pageof 46
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke OutcomeMagdalena Litman, Sara Azarpeykan, Rebecca J Hood, et al.
JACC. Cardiooncology|November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure SymptomsEsther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Circulation Research|December 25, 2018
CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial ActivationVanessa H Brait, Francesc Miró-Mur, Isabel Pérez-de-Puig, et al.
International Journal of Cancer|September 16, 2014
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerLorena Alonso-Alconada, Maria Santacana, Pablo Garcia-Sanz, et al.
Circulation. Heart Failure|May 9, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid CardiomyopathyAhmad Masri, Francesco Cappelli, Margot K Davis, et al.
Journal of the American Heart Association|November 4, 2024
Clinical Features and Outcomes of Pediatric <i>MYH7</i>-Related Dilated CardiomyopathyFernando de Frutos, Juan Pablo Ochoa, Gregory Webster, et al.
JACC. Basic to Translational Science|May 6, 2020
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure TrialInes Garcia-Lunar, Isabel Blanco, Leticia Fernández-Friera, et al.
JACC. Heart Failure|April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic CardiomyopathyAhmad Masri, Martin S Maron, Theodore P Abraham, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCharles F Sherrod, Sara Saberi, Michael E Nassif, et al.
BMC Medicine|January 14, 2022
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infectionFeargal J Ryan, Christopher M Hope, Makutiro G Masavuli, et al.
Pageof 46

Showing results (341-350 of 455) with videos related to

Sort By:
Pageof 46
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2025
Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke OutcomeMagdalena Litman, Sara Azarpeykan, Rebecca J Hood, et al.
JACC. Cardiooncology|November 29, 2022
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure SymptomsEsther Gonzalez-Lopez, Luis Escobar-Lopez, Laura Obici, et al.
Circulation Research|December 25, 2018
CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial ActivationVanessa H Brait, Francesc Miró-Mur, Isabel Pérez-de-Puig, et al.
International Journal of Cancer|September 16, 2014
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerLorena Alonso-Alconada, Maria Santacana, Pablo Garcia-Sanz, et al.
Circulation. Heart Failure|May 9, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid CardiomyopathyAhmad Masri, Francesco Cappelli, Margot K Davis, et al.
Journal of the American Heart Association|November 4, 2024
Clinical Features and Outcomes of Pediatric <i>MYH7</i>-Related Dilated CardiomyopathyFernando de Frutos, Juan Pablo Ochoa, Gregory Webster, et al.
JACC. Basic to Translational Science|May 6, 2020
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure TrialInes Garcia-Lunar, Isabel Blanco, Leticia Fernández-Friera, et al.
JACC. Heart Failure|April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic CardiomyopathyAhmad Masri, Martin S Maron, Theodore P Abraham, et al.
Journal of the American College of Cardiology|September 1, 2024
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCharles F Sherrod, Sara Saberi, Michael E Nassif, et al.
BMC Medicine|January 14, 2022
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infectionFeargal J Ryan, Christopher M Hope, Makutiro G Masavuli, et al.
Pageof 46